[Treatment of mild to moderate essential arterial hypertension with timolol alone and in combination with hydrochlorothiazide + amiloride. A multicenter, double-blind, cross-over study].
D000584:Amiloride / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D004311:Double-Blind Method; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D010919:Placebos; D011188:Potassium / Q000097:blood; D011412:Propanolamines / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D013999:Timolol / Q000627:therapeutic use*
D010919:Placebos; D011412:Propanolamines; D011719:Pyrazines; D006852:Hydrochlorothiazide; D000584:Amiloride; D013999:Timolol; D003404:Creatinine; D011188:Potassium
Behandling af let til moderat essentiel arterial hypertension med timolol alene og i kombination med hydroklortiazid + amilorid. En multicenter, dobbeltblind overkrydsningsundersøgelse.